13F HOLDINGS REPORT
ENAVATE SCIENCES GP, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001953107-25-000014
Total Value
$327.5M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ZENAS BIOPHARMA INC | ZBIO | 3,761,359 | $83.5M | 25.49% |
| 2 | SIONNA THERAPEUTICS INC | SION | 2,478,030 | $72.9M | 22.25% |
| 3 | IMMUNOME INC | IMNM | 4,768,583 | $55.8M | 17.05% |
| 4 | UPSTREAM BIO INC | UPB | 2,459,703 | $46.3M | 14.13% |
| 5 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 2,626,946 | $30.4M | 9.29% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 7,788,150 | $27.3M | 8.32% |
| 7 | CAMP4 THERAPEUTICS CORP | CAMP | 3,785,802 | $11.4M | 3.47% |